Hosted by American Conference Institute, the 11th Annual Advanced Forum on False Claims and Qui Tam Enforcement returns for another exciting year for lively discussions on FCA.
This week at the ABA's 37th Annual National Institute on White Collar Crime in foggy San Francisco, a panel of consumer fraud practitioners and enforcers offered insights.
On December 9, 2021, one of the nation's top healthcare prosecutors made clear that clinical trial fraud will be a major enforcement priority of President Joe Biden's Department of Justice.
On December 9, 2021, one of the nation’s top healthcare prosecutors made clear that clinical trial fraud will be a major enforcement priority of President Joe Biden’s Department of.
To embed, copy and paste the code into your website or blog:
As 2020 drew to a close, Indivior PLC, a global pharmaceutical company and manufacturer of the opioid treatment Suboxone, was sentenced in the U.S. District Court for the Western District of Virginia for making false statements to the Massachusetts Medicaid program about the relative safety of Suboxone Film around children to increase its sales, in violation of 18 U.S.C. § 1035. The Indivior sentencing closed out yet another significant, multifaceted investigation led by the U.S. Department of Justice (DOJ or the Department) that resulted in $2 billion in civil and criminal penalties, as well as multiple felony guilty pleas by the company and individual executives. Though DOJ s ability to extract hefty monetary settlements may no longer be newsworthy in light of its banner 2020 year, pointed comments by prosecutors on Indivior s sentencing in an interview with